SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-268816
Filing Date
2023-11-02
Accepted
2023-11-02 07:11:04
Documents
32
Period of Report
2023-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d536006d8k.htm   iXBRL 8-K 34964
2 EX-99.1 d536006dex991.htm EX-99.1 22575
3 EX-99.2 d536006dex992.htm EX-99.2 22503
7 GRAPHIC g536006ex99_2p10g1.jpg GRAPHIC 388292
8 GRAPHIC g536006ex99_2p11g1.jpg GRAPHIC 341790
9 GRAPHIC g536006ex99_2p12g1.jpg GRAPHIC 363772
10 GRAPHIC g536006ex99_2p13g1.jpg GRAPHIC 328501
11 GRAPHIC g536006ex99_2p14g1.jpg GRAPHIC 259586
12 GRAPHIC g536006ex99_2p15g1.jpg GRAPHIC 44988
13 GRAPHIC g536006ex99_2p16g1.jpg GRAPHIC 302840
14 GRAPHIC g536006ex99_2p1g1.jpg GRAPHIC 408648
15 GRAPHIC g536006ex99_2p2g1.jpg GRAPHIC 80196
16 GRAPHIC g536006ex99_2p3g1.jpg GRAPHIC 381812
17 GRAPHIC g536006ex99_2p4g1.jpg GRAPHIC 347000
18 GRAPHIC g536006ex99_2p5g1.jpg GRAPHIC 290674
19 GRAPHIC g536006ex99_2p6g1.jpg GRAPHIC 355696
20 GRAPHIC g536006ex99_2p7g1.jpg GRAPHIC 350388
21 GRAPHIC g536006ex99_2p8g1.jpg GRAPHIC 428224
22 GRAPHIC g536006ex99_2p9g1.jpg GRAPHIC 301219
23 GRAPHIC g536006img01.jpg GRAPHIC 21477
24 GRAPHIC g536006img02.jpg GRAPHIC 5136
  Complete submission text file 0001193125-23-268816.txt   7110798

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ntla-20231102.xsd EX-101.SCH 2847
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20231102_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20231102_pre.xml EX-101.PRE 11259
26 EXTRACTED XBRL INSTANCE DOCUMENT d536006d8k_htm.xml XML 3353
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 231370044
SIC: 2835 In Vitro & In Vivo Diagnostic Substances